48
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Life-threatening asthma attack during prolonged fingolimod treatment: case report

, , &
Pages 987-989 | Published online: 14 Jul 2014

References

  • BrinkmannVCysterJGHlaTFTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier functionAm J Transplant2004471019102515196057
  • BrinkmannVFTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous systemBr J Pharmacol200915851173118219814729
  • KapposLRadueEWO’ConnorPFREEDOMS Study GroupA placebo-controlled trial of oral fingolimod in relapsing multiple sclerosisN Engl J Med2010362538740120089952
  • CohenJABarkhofFComiGTRANSFORMS Study GroupOral fingolimod or intramuscular interferon for relapsing multiple sclerosisN Engl J Med2010362540241520089954
  • AmmitAJHastieATEdsallLCSphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthmaFASEB J20011571212121411344091
  • BoultonCMeiserKDavidOJSchmouderRPharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose studyJ Clin Pharmacol201252121879189022174429
  • PelletierDHaflerDAFingolimod for multiple sclerosisN Engl J Med2012366433934722276823